QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, net loss was USD 0.199468 million compared to USD 0.199003 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 USD | -.--% | -.--% | -49.37% |
1st Jan change | Capi. | |
---|---|---|
-49.37% | 315K | |
+8.88% | 219B | |
+8.68% | 185B | |
+14.25% | 135B | |
+28.18% | 107B | |
+14.65% | 51.28B | |
+4.48% | 51.01B | |
+4.39% | 41.85B | |
+7.00% | 37.02B | |
+26.06% | 31.27B |